TNFSF10 and liver cancer: When DNMT2 is absent, FTO expression increases, leading to a decrease in the m6A methylation level of TNFSF10, which in turn upregulates TNFSF10 expression and significantly inhibits the proliferation and metastasis of DNMT2-deficient liver cancer cells.